PACTR2010050002141682尚未招募未知
A randomised placebo controlled trial of oral iron therapy for treatment of post-malaria anaemia in Malawian children comparing immediate post-discharge or delayed treatment on haematological response and iron uptake
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 4 Month(s) 至 24 Month(s)（—）
- 性别
- All
入选标准
- •¿Age between 4 and 24 months
- •¿Have moderate anaemia (Hb 7.0-10.0 g/dL or PCV 21 ¿ 30%)
- •¿Have documented uncomplicated malaria and have completed treatment with Lumefantrine artemether (LA)
- •¿HIV seronegative
- •¿Be resident in the study catchment area
- •¿Have no known adverse reactions to oral iron
- •¿Weigh 5 kg or more
- •¿Had not used the study medication in the month preceding enrolment
- •¿Have written informed consent from a parent / guardian to participate in the study
排除标准
- •¿severe malnutrition (weight-for-height <75% of expected, the presence of bi-pedal oedema)
- •¿severe anaemia (Hb <7.0 g/dl or PCV <21%)
- •¿persistent diarrhea
- •¿Severe concomitant disease process
研究者
相似试验
尚未招募
不适用
Randomized controlled trial to compare oral iron to parenteral iron therapy for correction of iron deficiency in chronic kidney disease.CTRI/2020/04/024881Dr Manu Dogra
已完成
4 期
HEMATOCRIT Trial: A randomised controlled trial of oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets for the correction of anaemia in peritoneal dialysis patientsdarbepoetin-treated peritoneal dialysis patientsAnaemia in peritoneal dialysis patients treated with darbepoetinRenal and Urogenital - Kidney diseaseACTRN12610000678099Amgen60
招募中
3 期
A randomised controlled trial of oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)Iron deficiency anaemiaRenal and Urogenital - Kidney diseaseACTRN12609000432213Professor David Johnson60
已完成
2 期
A clinical trial to evaluate iron preparation effect for the pulmonary hypertension secondary in chronic respiratory disease patientsChronic respiratory failure patients with pulmonary arterial hypertensionJPRN-UMIN000007840Osaka City General Hospital Department of Respiratory Medicine41
进行中（未招募）
不适用
A clinical open, randomised study of oral iron (Duroferon®) vs. intravenous iron (Ferinject®) for iron substitution in blood donors.Iron deficiency.MedDRA version: 9.1Level: LLTClassification code 10022972Term: Iron deficiency anaemiaMedDRA version: 9.1Level: LLTClassification code 10022975Term: Iron deficiency anemia secondary to blood loss (chronic)EUCTR2009-010623-64-SERenapharma AB210